Short doxycycline course for anal chlamydia infection
Part of Infections clinical trials.
This trial tests whether a 7-day course of doxycycline is effective for treating an anal chlamydia infection (lymphogranuloma venereum) in people who do not have symptoms. Participants will take the antibiotic for a week and be followed for four weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and born male.
- You must have tested positive for lymphogranuloma venereum (a type of chlamydia) in an anal sample.
- You must have already taken doxycycline for at least 2 days, but not more than 7 days.
- You must not have any anorectal symptoms (like pain, discharge, or bleeding).
- You must be able to attend follow-up visits for 4 weeks.
- You must not be taking certain other antibiotics or blood thinners, or have a known allergy to doxycycline.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a single 200 mg dose of doxycycline works in the body to prevent bacterial sexually transmitted infections (like chlamydia, gonorrhea, and syphilis) after a risky sexual encounter. It is for men who have sex with men and are already on PrEP or living with HIV.
This study looks at taking doxycycline to prevent sexually transmitted infections (STIs) in men who have sex with men. It focuses on how this approach might affect the body's resistance to antibiotics.
This study tests whether taking a daily antibiotic (doxycycline) can prevent sexually transmitted infections in people at high risk. If you've had an STI recently and sometimes have sex without condoms, you might be able to join.
This study tests whether taking a short course of the antibiotic doxycycline after sex can prevent bacterial STIs (like chlamydia, gonorrhea, and syphilis) in women at higher risk. It lasts one year and uses a smartphone app to track your health.
This trial tests a combination of medications (doxycycline, pentoxifylline, and nitazoxanide) in men with untreated gonorrhea and chlamydia. It may help clear the infection more effectively, but you must meet specific safety and health criteria.
This trial tests whether taking doxycycline can lower the chance of getting bacterial sexually transmitted infections like syphilis, gonorrhea, and chlamydia. It is aimed at men who have had these infections recently and expect to keep having multiple male partners.
Hear when a new Lymphogranuloma Venereum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.